FDA pharmacologic class
Erythropoiesis-stimulating Agent
3 medicines are in FDA's class of erythropoiesis-stimulating agents: epoetin (Retacrit), darbepoetin alfa (Aranesp) and methoxy polyethylene glycol-epoetin beta (Mircera). 0 of the 3 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is epogen 2,000 units/ml vial at $32.27 per mL (NADAC).
Which medicines are erythropoiesis-stimulating agent?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Epoetin | Retacrit, Procrit, Epogen | none listed | $32.27 per mL 2,000 units/mL vial | Yes | No current entry | 2 |
| Darbepoetin alfa | Aranesp | none listed | $446.58 per mL 25 mcg/0.42 mL syring | Yes | No current entry | 0 |
| Methoxy polyethylene glycol-epoetin beta | Mircera | none listed | n/a | Yes | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price